This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Amur Minerals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Bob Young
Chief executive officer
US$316.0k
Total compensation
CEO salary percentage
100.00%
CEO tenure
19yrs
CEO ownership
n/a
Management average tenure
no data
Board average tenure
12.4yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Bob Young's remuneration changed compared to Amur Minerals's earnings?
Date
Total Compensation
Salary
Company Earnings
Jun 30 2023
n/a
n/a
-US$3m
Mar 31 2023
n/a
n/a
-US$3m
Dec 31 2022
US$316k
US$316k
-US$3m
Jun 30 2022
n/a
n/a
-US$4m
Mar 31 2022
n/a
n/a
-US$3m
Dec 31 2021
US$318k
US$318k
-US$2m
Jun 30 2021
n/a
n/a
-US$922k
Mar 31 2021
n/a
n/a
-US$2m
Dec 31 2020
US$316k
US$316k
-US$3m
Sep 30 2020
n/a
n/a
-US$3m
Jun 30 2020
n/a
n/a
-US$3m
Mar 31 2020
n/a
n/a
-US$2m
Dec 31 2019
US$316k
US$316k
-US$2m
Sep 30 2019
n/a
n/a
-US$3m
Jun 30 2019
n/a
n/a
-US$3m
Mar 31 2019
n/a
n/a
-US$3m
Dec 31 2018
US$316k
US$316k
-US$3m
Sep 30 2018
n/a
n/a
-US$4m
Jun 30 2018
n/a
n/a
-US$4m
Mar 31 2018
n/a
n/a
-US$3m
Dec 31 2017
US$316k
US$316k
-US$1m
Sep 30 2017
n/a
n/a
-US$2m
Jun 30 2017
n/a
n/a
-US$2m
Mar 31 2017
n/a
n/a
-US$4m
Dec 31 2016
US$316k
US$316k
-US$6m
Compensation vs Market: Bob's total compensation ($USD316.00K) is below average for companies of similar size in the US market ($USD740.57K).
Compensation vs Earnings: Bob's compensation has been consistent with company performance over the past year.
CEO
Bob Young (68 yo)
19yrs
Tenure
US$316,000
Compensation
Mr. Robin Jay Young, also known as Bob, has been the Chief Executive Officer of Amur Minerals Corporation since October 15, 2004 and its Executive Director since January 5, 2006. Mr. Young also serves as S...
Board Members
Name
Position
Tenure
Compensation
Ownership
Robin Young
CEO, Secretary & Executive Director
17.8yrs
US$316.00k
no data
Robert Schafer
Independent Non-Executive Chairman
17.8yrs
US$58.00k
no data
Paul Gazzard
Independent Non-Executive Director
7.1yrs
US$62.00k
no data
Thomas Bowens
Independent Non-Executive Director
4.2yrs
US$50.00k
no data
12.4yrs
Average Tenure
64yo
Average Age
Experienced Board: AMMC.F's board of directors are seasoned and experienced ( 12.4 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/10/07 10:47
End of Day Share Price
2023/07/10 00:00
Earnings
2023/06/30
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CRISM Therapeutics Corporation is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.